Pyrazolyl derivatives useful as anti-cancer agents
US11702409B2 · kind B2 · utility
0Cited by
0References
34Claims
0Family size
Assignee
Inventors
Key dates
| Filing date | Dec 17, 2020 |
| Grant date | Jul 18, 2023 |
| Priority date | — |
| Expiry date | Jun 2, 2041 |
Classification
- Technology area (CPC C)Chemistry; Metallurgy
- CPC primaryC07B2200/13
- WIPO fieldOrganic fine chemistry
- WIPO sectorChemistry
Abstract
The present invention provides a compound of formula (I) or a stereoisomer thereof, or an atropisomer thereof, or a pharmaceutically acceptable salt thereof, or a pharmaceutically acceptable salt of a stereoisomer thereof, or a pharmaceutically acceptable salt of an atropisomer thereof; a method for manufacturing said compound, and its therapeutic uses. The present invention further provides a combination of pharmacologically active agents and a pharmaceutical composition comprising said compound.
Source: USPTO / EPO open patent data. Objective bibliographic and citation counts.